| 产品详情 |
| Edit |   |
|---|
| Antigenic Specificity | Ki-67 proliferation Marker |
|---|
| Clone | polyclonal |
|---|
| Host Species | Rabbit |
|---|
| Reactive Species | human, mouse, rat |
|---|
| Isotype | n/a |
|---|
| Format | Protein A purified |
|---|
| Size | 100ul |
|---|
| Concentration | 1ug/ul |
|---|
| Applications | IHC-P, IF(IHC-P), IF(ICC) |
|---|
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
|---|
| Description | Ki-67 (Proliferation Marker) Antibody. • Target Background: Proliferation Marker Ki67 antigen is the prototypic cell cycle related nuclear protein, expressed by proliferating cells in all phases of the active cell cycle (G1, S, G2 and M phase). It is absent in resting (G0) cells. Ki67 are useful in establishing the cell growing fraction in neoplasms (immunohistochemically quantified by determining the number of Ki67 positive cells among the total number of resting cells = Ki67 index). In neoplastic tissues the prognostic value is comparable to the tritia |
|---|
| Immunogen | KLH conjugated synthetic peptide derived from human Ki67 . Immunogen Range: 1250-1300/3256 |
|---|
| Other Names | KIA; MIB-; MIB-1; PPP1R15; Antigen KI-67; MKI67 |
|---|
| Gene, Accession # | Gene ID: 4288, SwissProt: P46013 |
|---|
| Catalog # | bs-2130R |
|---|
| Price | |
|---|
| Order / More Info | Ki-67 proliferation Marker Antibody from BIOSS ANTIBODIES |
|---|
| Product Specific References | Kim, K. et al. (2014) Acta Otolaryngol. PubMed: 24460153 // Ma, Ying-Yu, et al. (2014) Onco Targets Ther. 637-643. PubMed: 24833907 // Ye, Qiurong, et al. (2014) PLoS ONE 9.7:e103298. PubMed: 25057912 // Li, Ning, et al. (2014) Biomaterials. PubMed: 25145854 // Luo, Xiaoming, et al. (2014) Int J Pharm. PubMed: 25218185 // Pan, Danyi, et al. (2014) Biomaterials. PubMed: 25263685 // Zhao, Yuechao, et al. (2014) Mol Endocrinol. PubMed: 25321413 // Yuan, Qing, et al. (2014) Int J Nanomedicine. 9:4829-46. PubMed: 25378924 // Yang, Fangfang, et al. (2015) Eur J Pharmacol. PubMed: 25720342 // Zhang, Jing-Yao, et al. (2015) World J Gastroenterol 21.14: 4195-4209. PubMed: 25892869 // Olianas, Maria, et al. (2015) Biochem Pharmacol. PubMed: 25888927 // Luo, Xiaoming, et al. (2015) Eur J Pharm Biopharm. PubMed: 26523356 // Zhao, Yuechao, et al. (2016) Endocrinology. // Ma, Wei-Yuan, et al. (2016) Exp Ther Med. PubMed: not posted yet // Antogenelli, Cinzia, et al. (2016) Free Radic Biol Med. PubMed: 26784015 // Li, Xin, et al. (2016) Acta Biomater. PubMed: 26873366 // Drel, Viktor R., et al. (2016) FASEB J. PubMed: 27221979 // Thompson, Christopher, et al. (2017) PLoS ONE. PubMed: 28187162 // He, Nan, et al. (2017) ACS Appl Mater Interfaces. PubMed: 28876891 // Liang, Guodong, et al.(2017) Acta Histochem. PubMed: 29173982 // Ma et al. (2016) Exp.Ther.Me. 11:631-636. PubMed: 26893658 // Dong et al. (2017) Oncotarget. 8:40583-40593. PubMed: 28489564 // Wu et al. (2018) Oncol.Lett. 15:1799-1810. PubMed: 29434876 // Cuellar et al. (2014) J.Histochem.Cytochem. 62:488-498. PubMed: 24789804 // Chen et al. (2015) PLoS.One. 10:e0144845. PubMed: 26680220 // Li et al. (2016) PLoS.One. 11:e0148273. PubMed: 26848572 // Zheng et al. (2016) Sci.Rep. 6:37414. PubMed: 27857213 |
|---|
| 产品资料 |
|
|